To summarize, in subjects with Alzheimer’s disease, caffeic acid decreases oxidative stress and improves cognitive functions, probably by inhibiting NF-κB and GSK3β signaling and acetylcholinesterase and butyrylcholinesterase activity (Figure 4). The gene discussed is ACHE; the disease is Alzheimer disease.